EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biomarkers for Diagnosis, Risk Stratification, and Immunotherapy of Pediatric Solid Tumors

Ewa Koscielniak, Katie Janeway, Stephen Gottschalk

American Society of Clinical Oncology Educational Book · 2026-06 · 46 (3)

DOI: 10.1200/edbk-26-519040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2026-06. Verfasst von Ewa Koscielniak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Eberhard Karls University, Tübingen, Germany. Hauptthemen laut MEDLINE: Neoplasms, Biomarkers, Tumor, Immunotherapy. Die Arbeit nennt 160 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a continued need to accurately diagnose, risk stratify, select treatment, and develop immunotherapies for extracranial pediatric solid tumors, and biomarkers are uniquely poised to meet this need. In most pediatric solid tumors, biomarkers are being used to enhance diagnostic accuracy and/or contribute to selection of risk-stratified systemic chemotherapy. Biomarker-selected targeted therapy and biomarker-informed immunotherapy approaches are less common. Liquid biopsy (LB) is emerging as an important prognostic biomarker in pediatric solid tumors. While the field is rapidly evolving with the exploration of novel technologies, challenges remain, including defining gold standard methods for LB in the clinic. In addition, biomarkers are still being explored as direct or indirect immunotherapeutic targets. In this review, we will provide a comprehensive overview of the biomarker landscape for the more common pediatric solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsBiomarkers, TumorImmunotherapyHumansChildRisk AssessmentPrognosisLiquid Biopsy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Medical Faculty, Eberhard Karls University, Tübingen, Germany.
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Department of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN.

Zitieren

APA

Koscielniak, E., Janeway, K., & Gottschalk, S. (2026). Biomarkers for Diagnosis, Risk Stratification, and Immunotherapy of Pediatric Solid Tumors. American Society of Clinical Oncology Educational Book, 46(3). https://doi.org/10.1200/edbk-26-519040

Vancouver

Koscielniak E, Janeway K, Gottschalk S. Biomarkers for Diagnosis, Risk Stratification, and Immunotherapy of Pediatric Solid Tumors. American Society of Clinical Oncology Educational Book. 2026;46(3). doi:10.1200/edbk-26-519040

BibTeX
@article{Koscielniak2026,
  author = {Koscielniak, Ewa and Janeway, Katie and Gottschalk, Stephen},
  title = {Biomarkers for Diagnosis, Risk Stratification, and Immunotherapy of Pediatric Solid Tumors},
  journal = {American Society of Clinical Oncology Educational Book},
  year = {2026},
  volume = {46},
  number = {3},
  doi = {10.1200/edbk-26-519040}
}
Kostenlos starten →